Profile of Pain and Unpleasant Sensations in Patients With Referred Pain

August 20, 2019 updated by: Shellie A. Boudreau, Aalborg University

Spatiotemporal Profile of Pain and Unpleasant Sensations in Referred Pain: a Feasibility Study

This feasibility study primarily aimed to assess the technology acceptance and usability of a pain tracking software in patients with spinally referred chronic pain. The secondary aim was to assess the fluctuations in pain intensity and distribution, using the pain tracking software during a 3-month period. Additionally, the study aimed to explore the patients' behavior when self-reporting pain when given the opportunity to use a variety of pain quality descriptors, such as tingling, burning and stabbing.

Patients with spinally referred chronic pain will be recruited to participate. Participants will be asked to use a pain tracking software to create weekly pain reports for a 3-month period. These pain reports consist of pain drawings and intensity scales. Additionally, patients will complete baseline disability and pain catastrophizing online questionnaires. The project does not affect treatment or does not offer any intervention.

Study Overview

Status

Completed

Intervention / Treatment

Study Type

Observational

Enrollment (Actual)

90

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Aalborg, Denmark, 9000
        • Aalborg University Hospital
      • Aalborg, Denmark, 9220
        • Aalborg University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 85 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Patients with referred pain recruited from advertisement in public areas, social media, public and collaborating private clinics and hospitals.

Description

Inclusion Criteria:

  • Suffer from pain in the neck or lumbar spine referring to a limb for a more than 7 consecutive days
  • Participant is willing and able to give informed consent for participation in the study.

Exclusion Criteria:

  • Pregnancy or breastfeeding, severe infections, cancer.
  • Epilepsy, Multiple sclerosis, history of stroke, diabetes, traumatic spinal cord injury resulting in permanent functions loss
  • Lack of ability to cooperate due to language barrier, cognition or inability to use technology.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Patients
Referred pain
The project does not affect treatment or does not offer any intervention.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in pain extent for 3 months
Time Frame: 3 months
Changes in pain extent as measured by the number of pixels drawn in digital pain drawings, at weekly intervals.
3 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in pain intensity for 3 months
Time Frame: 3 months
Changes in usual and current pain intensity as measured by a Numerical Rating Scale, at a weekly interval.
3 months
Changes in pain location for 3 months
Time Frame: 3 months
Changes of the location of pain measured by appearance and disappearance of pain in different body regions.
3 months
Disability levels at baseline
Time Frame: Baseline
Description of disability levels as assessed by the Oswestry (if pain located in back) or the Neck Disability Index (if pain located in neck) online questionnaires.
Baseline
Pain Catastrophizing score
Time Frame: Baseline
Scores obtained from an online Pain Catastrophizing Scale (PCS) at baseline
Baseline

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Demographic information
Time Frame: At baseline
Online demographic information
At baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Shellie A Boudreau, PhD, Associate Professor

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

March 30, 2018

Primary Completion (ACTUAL)

June 1, 2019

Study Completion (ACTUAL)

July 31, 2019

Study Registration Dates

First Submitted

June 7, 2018

First Submitted That Met QC Criteria

April 23, 2019

First Posted (ACTUAL)

April 24, 2019

Study Record Updates

Last Update Posted (ACTUAL)

August 21, 2019

Last Update Submitted That Met QC Criteria

August 20, 2019

Last Verified

August 1, 2019

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

IPD Plan Description

The location of the advanced analyses may occur in collaboration with other machine learning experts

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe